Filing Details
AGENUS INC (NASDAQ:AGEN) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event.
8k filedNASDAQ:AGEN
AGENUS INC (AGEN) Reports Material Event to SEC
Filing Details AGENUS INC (NASDAQ:AGEN) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event. Market Context AGENUS INC's…
Market Context
AGENUS INC's stock currently trades at $6.12 with a market capitalization of $113.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for AGENUS INC's stock.
All SEC filings for AGENUS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AGEN Stock Page
Frequently Asked Questions
Where can I read AGEN's SEC filings?
Browse all filings on our AGEN SEC filings page.
What types of SEC filings does AGENUS INC file?
Public companies like AGENUS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.